The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 330:576-577 February 24, 1994 Number 8
NextNext

Bilateral Anterior Uveitis: A Feature of Streptokinase-Induced Serum Sickness

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: Streptokinase is a commonly used thrombolytic agent. An unusual but well-documented adverse reaction is serum sickness1. Serum sickness typically develops one to two weeks after exposure to an antigen, with manifestations ranging from asymptomatic cutaneous eruptions to severe conditions such as glomerulonephritis, vasculitis, or pericarditis. Other features include fever, arthralgias, albuminuria, lymphadenopathy, and dependent edema. The condition usually resolves after withdrawal of the causative agent, but systemic corticosteroid therapy may be indicated if end-organ damage is severe. We report a case of serum sickness in which uveitis was a presenting feature.

A 54-year-old man was admitted . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.